Answers are grounded in this paper and cite their sources.
Mitochondrial dysfunction in patients with COPD is associated with excessive mitochondrial ROS levels, which contribute to enhanced inflammation and cell hyperproliferation. Targeting mitochondrial ROS represents a promising therapeutic approach in patients with COPD.
No takes yet. Share an insight, caveat, or question.
Wiegman et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: